Evidence map›Paper›PMID 32863365›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass.

Koushiro Ohtsubo, Kaname Yamashita, Naohiro Yanagimura, Chiaki Suzuki, Azusa Tanimoto, Akihiro Nishiyama, Shinji Takeuchi, Noriko Iwaki, Mitsuhiro Kawano, Akira Izumozaki and 5 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Koushiro OhtsuboDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Kaname YamashitaDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Naohiro YanagimuraDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Chiaki SuzukiDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Azusa TanimotoDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Akihiro NishiyamaDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Shinji TakeuchiDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Noriko IwakiDepartment of Hematology, Kanazawa University, Japan.
Mitsuhiro KawanoDepartment of Rheumatology, Kanazawa University, Japan.
Akira IzumozakiDepartment of Radiology, Kanazawa University, Japan.
Dai InoueDepartment of Radiology, Kanazawa University, Japan.
Toshifumi GabataDepartment of Radiology, Kanazawa University, Japan.
Hiroko IkedaDivision of Human Pathology, Kanazawa University, Japan.
Michio WatanabeGastroenterology, Hoju Memorial Hospital, Japan.
Seiji YanoDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Kanazawa University · JPHosyu Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimmune pancreatitis. Her serum IgG4 concentration was elevated to 674 mg/dL. After the pancreatic head mass spontaneously diminished, three masses were detected in the common bile duct. A biopsy of the major papilla revealed high-grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangement. Systemic chemotherapy with rituximab plus etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin resulted in complete remission.

Indexed as

Autoimmune PancreatitisLymphoma, Large B-Cell, DiffuseAgedAntineoplastic Combined Chemotherapy ProtocolsBile DuctsFemaleHumansPrednisoneProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6PrednisoneProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6automiine pancreatitisbile ducthigh-grade B-cell lymphomaIgG4-related diseasenon-Hodgkin lymphomawith MYC and BCL2 and/or BCL6 rearrangements

Identifiers

PMID32863365
PMCPMC7925286
OpenAlexW3082607553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.